Skip to content
Axcess News – Lifestyle
Author:
Tempest Therapeutics
Tempest Therapeutics Announces Up To $6 Million Private Placement
March 23, 2026
Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
March 11, 2026
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
March 5, 2026
←
Previous Page
1
2